Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estudo Randomizado de Fase II Com Capecitabina Versus 5-Fluorouracil/Leucovorin em Bolus Associados à Radioterapia no Tratamento Neoadjuvante de câncer de Reto Localmente avançado: INCAGI004.

NCT03428529 is registered in ClinicalTrials.gov with Instituto Nacional de Cancer, Brazil as lead sponsor.

NCT NCT03428529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03428529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estudo Randomizado de Fase II Com Capecitabina Versus 5-Fluorouracil/Leucovorin em Bolus Associados à Radioterapia no Tratamento Neoadjuvante de câncer de Reto Localmente avançado: INCAGI004.
Lead sponsor
Instituto Nacional de Cancer, Brazil
Phase
Phase 2/3
Overall status
Completed
Start date
January 12, 2011
Completion date
December 13, 2016
Enrollment
63 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rectal neoplasm malignant